【银诺医药港股IPO及境内未上市股份“全流通”获中国证监会备案】中国证监会国际合作司发布关于广州银诺医药集团股份有限公司境外发行上市及境内未上市股份“全流通”备案通知书,公司拟发行不超过69,043,500股境外上市普通股并在香港联合交易所上市。公司45名股东拟将所持合计383,729,000股境内未上市股份转为境外上市股份,并在香港联合交易所上市流通。

金融界
29 May
中国证监会国际合作司发布关于广州银诺医药集团股份有限公司境外发行上市及境内未上市股份“全流通”备案通知书,公司拟发行不超过69,043,500股境外上市普通股并在香港联合交易所上市。公司45名股东拟将所持合计383,729,000股境内未上市股份转为境外上市股份,并在香港联合交易所上市流通。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10